Your browser doesn't support javascript.
loading
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
Mol Cancer Ther ; 6(8): 2158-67, 2007 Aug.
Article in En | MEDLINE | ID: mdl-17671083
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Colorectal Neoplasms / Signal Transduction / Receptor, IGF Type 1 / Protein Kinase Inhibitors / Imidazoles / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2007 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Colorectal Neoplasms / Signal Transduction / Receptor, IGF Type 1 / Protein Kinase Inhibitors / Imidazoles / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2007 Type: Article Affiliation country: United States